Needs and Preferences of Patients With Head-neck Cutaneous SCC

NCT06046625 · tracked via the Priya Life Science Netherlands tracker

Sponsor

Maastricht University Medical Center

Phase

Observational

Started

2021-11-01

Last updated

2025-04-04

Condition(s) studied

Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell CarcinomaSquamous Cell Carcinoma of Head and NeckSquamous Cell Carcinoma of the Head and NeckSkin CancerPatient SatisfactionHigh-Risk CancerPreference, PatientDecision MakingInterview

Investigational drug(s) / intervention(s)

Regular care with additional administration of a semi-structured interview

Regular care with additional administration of a semi-structured interview: Patients receiving regular care. In addition, a semi-structured interview is conducted. The semi-structured interviews take place once after completion of the care pathway (after all appointments for check-ups associated with the treatment). The interview contains questions about the experience of patients with the care, the needs in this care, the experiences with the information received, the support/guidance, the turnaround time, the treatment received and areas for improvement.

Study summary

The care of patients with high-risk cutaneous squamous cell carcinomas in the head-neck area is complex and requires a multidisciplinary approach. A key component in this care is the need and experience of patients. However, studies on the experiences and needs of patients with high-risk cutaneous squamous cell carcinomas in the head-neck region are lacking.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients diagnosed with a cSCC, located in the head-neck region * who visited the multidisciplinary head-neck team of the Maastricht University Medical Center+ * who already received treatment for their cSCC * who gave informed consent for participation Exclusion Criteria: \- patients who are cognitively impaired for participation in an interview

Primary outcome measure(s)

Themes patients — Through study completion, an average of 1 year
The emerging themes of patient needs an experiences in the care of cutaneous squamous cell carcinoma in the head-neck region.
Themes professionals — Through study completion, an average of 1 year
The emerging themes of professionals' needs in the care of patients with cutaneous squamous cell carcinoma in the head-neck area.

Trial sites (1)

Facility	City	Region	Status
Maastricht University Medical Center+	Maastricht	Netherlands

More Maastricht University Medical Center trials in the Netherlands

Re-evaluation of the Muscle-full Effect During Continuously Elevated Amino Acid Availability in Healthy Young Males Starting soon

Frequency of Interrupting Sitting and Cognitive Function Recruiting

High-Dairy Food Patterns and Gut-Brain Axis Starting soon

Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas Recruiting

Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients Recruiting

Other trials for the same condition

Towards Cure Via Only Ultra-short ICB in CSCC Recruiting

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer Recruiting

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer Active, not recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting

Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06046625 on ClinicalTrials.gov ↗ ← All trials in the Netherlands